Breaking News Instant updates and real-time market news.

AMZN

Amazon.com

$1,688.82

15 (0.90%)

14:05
11/30/18
11/30
14:05
11/30/18
14:05

Amazon pullback creates 'major buying opportunity,' says Tigress Financial

The recent decline in shares of Amazon.com creates a "major buying opportunity," Tigress Financial analyst Ivan Feinseth tells investors in a research note. The analyst reiterates a Buy rating on the shares and added Amazon to his firm's Research Focus List and Focus Opportunity Portfolio. The company's distribution strength and fulfillment platform is accelerating the growth of its global footprint, contends Feinseth. Further, he believes Amazon's Prime membership continues to drive its retail expansion as it grows its brick-and-mortar retail presence. He sees "significant upside" potential in the shares.

  • 04

    Dec

AMZN Amazon.com
$1,688.82

15 (0.90%)

11/30/18
RBCM
11/30/18
NO CHANGE
Target $200
RBCM
Outperform
VMware price target raised to $200 from $180 at RBC Capital
RBC Capital analyst Matthew Hedberg raised his price target on VMWare (VMW) to $200 and kept his Outperform rating after its "strong" Q3 results and initial FY20 outlook that calls for revenue growth of 12% - better than the consensus of 8%. The analyst believes that the results highlight the "impressive acceleration at scale and increasing role in driving customers' hybrid cloud initiatives", also raising his FY19 EPS view by 6c to $6.20 and FY20 by 5c to $6.73. Hedberg is also positive on VMWare's growing relationship with Amazon's (AMZN) AWS and the "potential for additional capital allocation beyond the current buyback", along with its "attractive valuation" and "under-owned" market status.
11/30/18
JEFF
11/30/18
UPGRADE
Target $47
JEFF
Buy
UDR, Inc. upgraded to Buy from Hold at Jefferies
Jefferies analyst Omotayo Okusanya upgraded UDR, Inc. (UDR) to Buy and raised his price target for the shares to $47 from $42. The company's above average net operating income growth and development pipeline position it to be one of the best funds from operations growth stories in 2019, Okusanya tells investors in a research note. Further, the analyst sees UDR as one of the biggest beneficiaries from Amazon's (AMZN) new headquarters. He notes the company owns one asset in New York with a commute under 30 minutes to the new Long Island City headquarters and three assets within a three-mile radius to the new headquarters in Arlington, Virginia.
11/29/18
JMPS
11/29/18
NO CHANGE
Target $2050
JMPS
Outperform
Amazon event showed AWS expanding its lead, says JMP Securities
After attending Amazon's AWS re:Invent conference, JMP Securities analyst Ronald Josey said he is more confident on AWS, citing the event's increased attendance, increased streaming audience and the multiple new products and services that were announced this week. Josey, who said AWS continues to expand its lead in the Cloud market, keeps an Outperform rating and $2,050 price target on Amazon shares.
11/28/18
KEYB
11/28/18
NO CHANGE
KEYB
KeyBanc sees Amazon entry having little near-term impact on HCIT space
The announcement that Amazon.com (AMZN) is developing Software-as-a-Service analytical tools for the U.S. healthcare industry called Amazon Comprehend Medical will likely bring a "lot of noise, but little real, near-term financial impact" to the publicly traded Healthcare Technology and Services space, KeyBanc analyst Donald Hooker tells investors in a research note. He believes companies potentially most relevant to Amazon's announcement include Allscripts Healthcare Solutions (MDRX), Cerner (CERN), Evolent Health (EVH), Inovalon Holdings (INOV), IQVIA Holdings (IQV), Medidata Solutions (MDSO), PRA Health Sciences (PRAH), Premier (PINC), and Teladoc Health (TDOC). Hooker argues that any potential success by mega-tech companies, such as Amazon, to develop useful SaaS analytical tools "could actually empower traditional HCIT and biopharma outsourcing companies." Further, he sees a number of "unique barriers" for "big data" solutions in clinical decision support and population health management.

TODAY'S FREE FLY STORIES

SPOT

Spotify

$142.01

-5.34 (-3.62%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Spotify debuts 'Soundtrack your Ride' feature to make playlists for road trips »

Over this past weekend,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 19

    Nov

DIS

Disney

$148.24

3.61 (2.50%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Periodicals
Disney+ accounts of thousands of users hacked, Cheddar says »

Disney+ users have…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:50
11/18/19
11/18
14:50
11/18/19
14:50
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BILI

Bilibili

$16.49

-0.22 (-1.32%)

14:49
11/18/19
11/18
14:49
11/18/19
14:49
Options
Bilibili options imply 13.3% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

BAP

Credicorp

$210.20

-0.45 (-0.21%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Hot Stocks
Credicorp reports testimony of chairman in Peruvian government investigation »

Credicorp announces that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OSTK

Overstock.com

$8.29

-0.03 (-0.36%)

14:45
11/18/19
11/18
14:45
11/18/19
14:45
Options
Overstock com call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

GSB

GlobalSCAPE

$10.14

0.09 (0.90%)

14:41
11/18/19
11/18
14:41
11/18/19
14:41
Hot Stocks
GlobalSCAPE announces $3.35 per share special cash dividend, $5M buyback program »

GlobalSCAPE announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ROKU

Roku

$162.37

5.115 (3.25%)

, NTDOY

Nintendo

$0.00

(0.00%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Periodicals
Roku rolls out fix after new 'Pokemon' games cause crashing problems, Verge says »

Roku (ROKU) confirmed…

ROKU

Roku

$162.37

5.115 (3.25%)

NTDOY

Nintendo

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

FB

Facebook

$197.78

2.71 (1.39%)

14:30
11/18/19
11/18
14:30
11/18/19
14:30
Hot Stocks
Facebook's Oculus Link launches beta to play PC Rift games wired to Quest »

Oculus said in-part in an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

14:28
11/18/19
11/18
14:28
11/18/19
14:28
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

GSB

GlobalSCAPE

$10.13

0.08 (0.80%)

14:26
11/18/19
11/18
14:26
11/18/19
14:26
Hot Stocks
Breaking Hot Stocks news story on GlobalSCAPE »

Globalscape trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CERN

Cerner

$67.76

-0.63 (-0.92%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Options
Cerner call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRHC

Tabula Rasa HealthCare

$41.26

-0.83 (-1.97%)

14:25
11/18/19
11/18
14:25
11/18/19
14:25
Conference/Events
Tabula Rasa HealthCare participates in a conference call with Benchmark »

Conference call with CFO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

DNA

Bought by RHHBY

$0.00

(0.00%)

14:23
11/18/19
11/18
14:23
11/18/19
14:23
Conference/Events
Wolfe Research pharma analyst to hold an analyst/industry webcast »

Global Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:18
11/18/19
11/18
14:18
11/18/19
14:18
Recommendations
MorphoSys analyst commentary  »

MorphoSys B-MIND futility…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/18/19
11/18
14:17
11/18/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/18/19
11/18
14:16
11/18/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOR

MorphoSys

$28.22

2.08 (7.96%)

14:14
11/18/19
11/18
14:14
11/18/19
14:14
Hot Stocks
MorphoSys says tafasitamab B-MIND study successfully passed futility analysis »

Earlier, MorphoSys…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

DISCA

Discovery

$30.74

1.03 (3.47%)

14:03
11/18/19
11/18
14:03
11/18/19
14:03
Hot Stocks
Discovery rises after Malone buys $75M worth of stock »

In a regulatory filing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$196.73

1.66 (0.85%)

14:01
11/18/19
11/18
14:01
11/18/19
14:01
Options
Call volume jumps in Facebook as shares and implied volatility lift »

Call volume jumps in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

ABMD

Abiomed

$190.75

-32.48 (-14.55%)

13:54
11/18/19
11/18
13:54
11/18/19
13:54
Hot Stocks
Abiomed falls after studies question Impella heart device at AHA 2019 meeting »

In a story out over the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNI

McClatchy

$0.56

0.0846 (17.63%)

13:53
11/18/19
11/18
13:53
11/18/19
13:53
Hot Stocks
Bluestone Financial raises stake in McClatchy to 11.85% »

Bluestone Financial holds…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HSII

Heidrick & Struggles

$29.39

-0.04 (-0.14%)

13:50
11/18/19
11/18
13:50
11/18/19
13:50
Initiation
Heidrick & Struggles initiated  »

Heidrick & Struggles…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

  • 20

    Nov

13:50
11/18/19
11/18
13:50
11/18/19
13:50
General news
Fed's Mester said she would have preferred to have kept rates steady »

Fed's Mester said…

CL

Colgate-Palmolive

$67.08

0.71 (1.07%)

13:45
11/18/19
11/18
13:45
11/18/19
13:45
Options
Colgate Palmolive call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.